00809 GLOBAL BIO-CHEM
- 0.107
- +0.012+12.63%
GLOBAL BIO-CHEM News
Global Corn Starch Market Analysis and Competitive Landscape Report 2024-2032 Featuring Cargill, Ingredion, ADM, Tate & Lyle, Associated British Foods, Tereos, Sudzucker, & Global Bio-Chem Technology - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Global Corn Starch Market Report by Type, Form, End-Use, Region and Company Analysis 2024-2032" report has been added to ResearchAndMarkets.com's offering.It is projected
大成生化科技：年報2023
Global Bio-chem Technology Returns to Profit in 2023 on Debt Restructuring, Asset Disposal
Global Bio-chem Technology Group Company (HKG:0809) swung to a profit in 2023, driven by one-off gains from its debt restructuring and asset disposal, according to a March 28 release. Attributable pro
Dacheng Biochemical Technology Announces 2023 Annual Results: Profit attributable to shareholders of HK$4.225 billion turned a year-on-year loss into a profit
Dacheng Biochemical Technology (00809) announced its annual results for the year ended December 31, 2023. The Group achieved revenue of HK$1,374 billion during the period, a significant increase over the previous year; profit attributable to company owners was HK$4.225 billion; loss attributable to company owners was HK$1,443 billion in the same period last year; basic profit per share was HK$47.4 cents.
Dacheng Biochemical Technology (00809) Announces 2023 Annual Results Profit attributable to shareholders of HK$4.225 billion, turning a year-on-year loss into profit
Dacheng Biochemical Technology (00809) announced its annual results for the year ended December 31, 2023. The group achieved...
GLOBAL BIO-CHEM: ANNOUNCEMENT OF THE FINAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2023
Dacheng Biochemical Technology (00809.HK) plans to hold a board meeting on March 28 to approve annual results
Glonghui, March 18, 丨 Dacheng Biochemical Technology (00809.HK) announced that the board of directors meeting will be held on March 28, 2024 to review and approve the annual results of the company and its subsidiaries for the year ended 31 December 2023 and consider the payment of a final dividend (if any).
GLOBAL BIO-CHEM: NOTICE OF BOARD MEETING
Global Bio-chem Technology Group Company Limited's (HKG:809) Shares Climb 26% But Its Business Is Yet to Catch Up
Global Bio-chem Technology Group Company Limited (HKG:809) shares have continued their recent momentum with a 26% gain in the last month alone. Not all shareholders will be feeling jubilant, since
Global Bio-chem Technology Expects Up to HK$4 Billion Gains in 2023; Shares Soar 10%
Global Bio-chem Technology Group (HKG:0809) expects to record a net gain of between HK$3.60 billion and HK$4 billion for 2023. The forecast was attributed to gains accumulated from debt restructuring
Announcement Highlights: NetEase Q4 net revenue increased 7% year-on-year to 27.14 billion yuan; Yuexiu Real Estate acquired land for 1,414 billion yuan
NetEase Cloud Music's revenue in 2023 was 7.87 billion yuan, turning a loss into a profit for the first time, and gross margin rose to 26.7%; Pacific Shipping had a turnover of US$2,297 billion in 2023, a year-on-year decrease of 30.02%.
Dacheng Biochemical Technology (00809) is expected to achieve annual net profit of HK$3.6 billion to HK$4 billion, turning a year-on-year loss into profit
Dacheng Biochemical Technology (00809) issued an announcement. Regarding the Group's continued operation and discontinued business, the Group expects to...
大成生化科技：內幕消息 盈利預告
Dacheng Biotech [00809] now reports HK$0.08, a decrease of 14.89%
As of 09:44, Dacheng Biochemical Technology [00809] reported HK$0.08, down HK$0.014 or 14.89% from yesterday's closing price, with a turnover of HK$0.14 million. Today's high price was HK$0.08, and the lowest price was HK$0.08. Based on yesterday's closing price, the 10-day average price was HK$0.10, and the 50-day average price was HK$0.09. The current price-earnings ratio was -0.58 times, and the 14-day strength and weakness index was reported at 40.00.
Ministry of Finance: The total profit of state-owned enterprises in 2023 was 4633.28 billion yuan, up 7.4% year-on-year
From January to December, the main efficiency indicators of state-owned and state-owned enterprises across the country continued to grow steadily, and the upward trend was further consolidated.
Global Bio-Chem Co-Founders Close Takeover Bid for Global Sweeteners
Global Sweeteners Holdings or GSH (HKG:3889) announced the close of the mandatory unconditional cash offer by CCB International and China Galaxy International on behalf of the joint offerors. The join
Global Bio-Chem Technology Units Enter Into 5 Billion Yuan Debt Restructuring Deals
Global Bio-Chem Technology Group (HKG:0809) subsidiaries entered into debt restructuring plans with Nongtou, or Jilin Agricultural Investment Group worth 5.08 billion yuan for three years ending Dec.
Dacheng Biochemical Technology [00809] is now reported at HK$0.094, an increase of 27.03%
As of 15:59 Dacheng Biochemical Technology [00809] reported HK$0.094, up HK$0.02 or 27.03% from yesterday's closing price of HK$0.074, with a turnover of HK$577,800, today's highest price of HK$0.094, and the lowest price of HK$0.066. Based on yesterday's closing price, the 10-day average price is HK$0.07 and the 50-day average price is HK$0.06. The current price-earnings ratio is -0.46 times, and the 14-day strength index is 68.00.
Dacheng Biochemical Technology [00809] is now reported at HK$0.066, a decrease of 10.81%
As of 09:30, Dacheng Biochemical Technology [00809] reported HK$0.066, down HK$0.008 or 10.81% from the closing price of HK$0.074 from yesterday, with a turnover of HK$47,800, today's highest price of HK$0.067, and the lowest price of HK$0.066. Based on yesterday's closing price, the 10-day average price is HK$0.07 and the 50-day average price is HK$0.06. The current price-earnings ratio is -0.46 times, and the 14-day strength index is 68.00.
Global Bio-Chem Technology Shareholders to Vote Dec. 31 on Proposed Issue of Convertible Preference Shares to 2 Parties
Shareholders of Global Bio-Chem Technology Group (HKG:0809) will meet on Dec. 31 to vote on the proposed issue of convertible preference shares to two equity investment companies at HK$0.10 apiece. Th
Analysis
Price Target
No Data
